Hitesh Patel, MD
Neurological Surgery · San Clemente, CANPI 1053573519
Payments from drug & device makers
Across 87 payments — averaging $11.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$688
- Novo Nordisk$57
- Pfizer$41
- Lilly USA, LLC$34
- Sanofi Pasteur Inc.$28
- Johnson & Johnson$26
- plus $146 from 8 others
What the payments were for
- Food & beverage$1,020100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 67 | $688 |
| Novo Nordisk | 3 | $57 |
| Pfizer | 3 | $41 |
| Lilly USA, LLC | 2 | $34 |
| Sanofi Pasteur Inc. | 2 | $28 |
| Johnson & Johnson | 2 | $26 |
| UCB, Inc. | 1 | $23 |
| Amgen | 1 | $19 |
| Novartis | 1 | $19 |
| Metuchen Pharmaceuticals | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Abbott | 1 | $18 |
| AstraZeneca | 1 | $18 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $12 |
How this compares
$1,020 in reported general payments places this provider in the 30th percentile of 773 neurological surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Emgality PenGalcanezumab-Gnlm | 30 | $20,966 |
| Memantine Hcl | 298 | $9,146 |
| TegretolCarbamazepine | 11 | $7,287 |
| Gabapentin | 270 | $3,516 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 95 | $3,283 |
| Levetiracetam | 69 | $1,666 |
| Phenytoin Sodium Extended | 24 | $1,165 |
| Pregabalin | 34 | $1,090 |
| Memantine Hcl ErMemantine Hcl | 16 | $1,056 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 38 | $878 |
| Primidone | 34 | $804 |
| Galantamine Hbr | 15 | $703 |
| Divalproex Sodium | 61 | $617 |
| Carbamazepine | 11 | $600 |
| Ropinirole Hcl | 18 | $457 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in San Clemente
- Geoffrey ManleySan Francisco$24.9M
- Christopher AmesSan Francisco$7.1M
- Jamshid SalehRedding$4.1M
- Bruce McCormackSan Francisco$3.9M
- Andrew SchreiberSanta Ana$3.9M
- Larry KhooLos Angeles$3M
- Jennie TaylorSan Francisco$2.7M
- Joseph CiacciSan Diego$2.6M
- Nicholas ButowskiSan Francisco$2.4M
- Samy AbdouSan Diego$2.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.